Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-22-000020

Chief Medical Officer sold 2,021 shares at an average $15.11 ($30,531)

  • Chief Medical Officer acquired 2,021 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KREHER NERISSA Chief Medical Officer 2022-09-08 Option exercise +1,221 $2.10 $2,564 21,937 D
KREHER NERISSA Chief Medical Officer 2022-09-08 Sale −1,221 $15.13 $18,478 20,716 D
KREHER NERISSA Chief Medical Officer 2022-09-09 Option exercise +800 $2.10 $1,680 21,516 D
KREHER NERISSA Chief Medical Officer 2022-09-09 Sale −800 $15.07 $12,054 20,716 D
Derivatives
KREHER NERISSA Chief Medical Officer 2022-09-08 Option exercise · Stock Option (Right to Buy) −1,221 29,811 D
KREHER NERISSA Chief Medical Officer 2022-09-09 Option exercise · Stock Option (Right to Buy) −800 29,011 D
Open-market sales · 2,021 sh · avg $15.11 · $30,531
Loading xslF345X03/wf-form4_166301390290805.xml…